US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

685.75

-15.2311-2.17%

Number of Gainers:61

Number of Losers:84

Number of Flat:9

PE:- -

High:703.53

Open:700.98

Low:685.46

Close:700.98

Volume:313.13M

Turnover:10.17B

Market Cap:479.55B

Float Cap:364.16B

Loading ...

Abeona Therapeutics Q2 Net Loss Widens, Misses Analyst Expectations

Canada's NeuPath Health Q2 Revenue Falls Despite Record Patient Visits

Aveanna Healthcare Raises 2026 Outlook After Strong Quarter

Aveanna Highlights Growth and Scale in Investor Presentation

Sprinklr Appoints Microsoft Search & AI Chief Jordi Ribas to Board

Sprinklr Appoints Jordi Ribas to Board of Directors

THOMSON REUTERS

Press Release: ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates

Cormedix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

AGL Energy (ASX:AGL) Shares Look Mispriced As Cash Holds Firm

Simply Wall St.

Lensar Q2 Revenue Rises 18%, Returns to Profit

Global-E Online Ltd. : Bofa Global Research Raises Price Objective to $52 from $44

THOMSON REUTERS

Mobix Labs Signs Deal to Acquire Rare Earth Supply-Chain Platform Special Project Delivery in All-Stock Transaction

Mobix Labs, - Spd Acquisition Consideration not to Exceed 4.8 Mln Mobix Shares

THOMSON REUTERS

Mobix Labs Signs Definitive Rare Earth Elements Deal, Expanding National Security Platform; Hosts Investor Call Today at 4:15Pm Et

THOMSON REUTERS

Aveanna Healthcare Q2 Revenue Beats on Broad-Based Growth

Beyond Air Q1 Net Loss Slightly Widens, Reaffirms 2026 Outlook

Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE), Mineralys Therapeutics, Inc. (MLYS) and Adagene (ADAG)

Lenz Therapeutics, Inc. : Bofa Global Research Cuts to Neutral from Buy; Cuts Price Objective to $7 from $31

THOMSON REUTERS

Aveanna Healthcare Shares up 7.3% Premarket After Q2 Revenue Beat

THOMSON REUTERS

Biomea Fusion Doses First Patient in OPAL Trial of Icovamenib Plus Semaglutide for Obesity

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BK4539/news?page=37"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":685.7458,"timestamp":1787601599999,"preClose":700.9769,"halted":0,"volume":313126904,"delay":0,"changeRate":-0.021728,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-15.23114,"latestTime":"08-24 16:00:00 EDT","open":700.9787,"high":703.53143,"low":685.4632,"amount":10165204650.256977,"amplitude":0.025776,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787664600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.245326,"peRate":150.969108,"turnoverRate":0.024191,"increases":61,"decrements":84,"flats":6,"marketCap":479546114433.625,"floatMarketCap":364158638649},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":703.53143,"amplitude":0.025776,"preClose":700.9769,"low":685.4632,"pbRate":"5.245326","latestPrice":685.7458,"volume":313126904,"delay":0,"open":700.9787,"prevYearClose":881.5255,"prevWeekClose":700.9769,"prevMonthClose":673.0273,"prevQuarterClose":742.922,"fiveDayClose":666.772,"twentyDayClose":702.6321,"sixtyDayClose":754.549,"secType":"PLATE","market":"US","turnoverRate":0.024191,"peRate":150.969108,"marketCap":479546114433.625,"floatMarketCap":364158638649,"timestamp":1787601599999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":61,"down":84,"flat":9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:37,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659014159","title":"Abeona Therapeutics Q2 Net Loss Widens, Misses Analyst Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2659014159","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659014159?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:39","pubTimestamp":1786621195,"startTime":"0","endTime":"0","summary":"Abeona Therapeutics Q2 net loss widens, misses analyst expectationsOverviewUS cell and gene therapy firm's Q2 net ZEVASKYN revenue rose 31% quarter-over-quarterQ2 net loss and loss per share missed an","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A0IC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","RCKT","TSHA","BK4505","IPSC","ABEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659159061","title":"Canada's NeuPath Health Q2 Revenue Falls Despite Record Patient Visits","url":"https://stock-news.laohu8.com/highlight/detail?id=2659159061","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659159061?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:38","pubTimestamp":1786621111,"startTime":"0","endTime":"0","summary":"Canada's NeuPath Health Q2 revenue falls despite record patient visitsOverviewCanada pain treatment clinic operator's Q2 revenue declined 2% yr/yrAdjusted EBITDA for Q2 fell 23% yr/yr, impacted by pri","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A0I5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVAH","BK4539","BK4196","BK4185","SGRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659151333","title":"Aveanna Healthcare Raises 2026 Outlook After Strong Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2659151333","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659151333?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:36","pubTimestamp":1786620999,"startTime":"0","endTime":"0","summary":"An announcement from Aveanna Healthcare Holdings ( ($AVAH) ) is now available. Aveanna Healthcare Holdings reported strong financial results for th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aveanna-healthcare-raises-2026-outlook-after-strong-quarter?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aveanna-healthcare-raises-2026-outlook-after-strong-quarter?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","HCSG","BK4588","XLV","LABU","XBI","BK4581","LU0029874061.USD","AVAH","LU0128526141.USD","BK4137","BK4539","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659151368","title":"Aveanna Highlights Growth and Scale in Investor Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2659151368","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659151368?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:36","pubTimestamp":1786620975,"startTime":"0","endTime":"0","summary":"Aveanna Healthcare Holdings ( ($AVAH) ) has shared an announcement. On August 13, 2026, Aveanna Healthcare Holdings Inc. released an investor prese...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aveanna-highlights-growth-and-scale-in-investor-presentation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aveanna-highlights-growth-and-scale-in-investor-presentation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","AVAH","BK4581","XLV","BK4539","BK4585","BK4196","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659159170","title":"Sprinklr Appoints Microsoft Search & AI Chief Jordi Ribas to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2659159170","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659159170?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:30","pubTimestamp":1786620625,"startTime":"0","endTime":"0","summary":"Sprinklr appoints Microsoft Search & AI chief Jordi Ribas to boardSprinklr appointed Jordi Ribas to its board of directors, effective Aug. 17, 2026.Ribas serves as President of Search & AI at Microsof","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL5CDWgz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","CXM","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659159187","title":"Sprinklr Appoints Jordi Ribas to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2659159187","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659159187?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:30","pubTimestamp":1786620600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA3YR6V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CXM","BK4539","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659159750","title":"Press Release: ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2659159750","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659159750?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:30","pubTimestamp":1786620600,"startTime":"0","endTime":"0","summary":"Second quarter 2026 net product revenue of $18.6 million; cash and cash equivalents of $219.1 million as of June 30, 2026LOTIS-7, LOTIS-5 and MZL IIT data submitted for presentation at ASHCompany eval","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","ASH","LABU","BK4195","LENZ","NETL","BK4505","BK4109","ADCT","PFS","BK4232","BK4539","BK4022","BK4007","BK4211","LU2463526074.USD","R","ADC","BK4585","BK4588","BK4231","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659151628","title":"Cormedix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659151628","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659151628?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:30","pubTimestamp":1786620600,"startTime":"0","endTime":"0","summary":" Q2 2026 Consolidated Revenue of$101.9 million   Q2 2026 Net Income of $26.0 million; Adjusted EBITDA of $58.7 million   Company Maintains FY 2026 Revenue and Raises Adjusted EBITDA Guidance   Confere","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/13/3344407/0/en/cormedix-therapeutics-reports-second-quarter-2026-financial-results-and-provides-business-update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659150351","title":"AGL Energy (ASX:AGL) Shares Look Mispriced As Cash Holds Firm","url":"https://stock-news.laohu8.com/highlight/detail?id=2659150351","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659150351?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:21","pubTimestamp":1786620067,"startTime":"0","endTime":"0","summary":"AGL Energy walked into this result priced like a problem stock, with a trailing P/E of 7.8x and the shares at A$8.71 despite a discounted cash flow estimate almost double that. The market has been treating the 12 month earnings outlook as the dominant story. Yet the headline from these numbers is different. Underlying net profit after tax of A$631m, supported by 97% cash conversion and a fully franked A$0.50 dividend for FY26, indicates that cash and profits are holding up better than...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9541000-choice2-main-header/1585186794818","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9541000-choice2-main-header/1585186794818"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/utilities/asx-agl/agl-energy-shares/news/agl-energy-asxagl-shares-look-mispriced-as-cash-holds-firm","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/utilities/asx-agl/agl-energy-shares/news/agl-energy-asxagl-shares-look-mispriced-as-cash-holds-firm","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4196","BK7136","BK4539","AGL","AGL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659215608","title":"Lensar Q2 Revenue Rises 18%, Returns to Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2659215608","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659215608?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:17","pubTimestamp":1786619859,"startTime":"0","endTime":"0","summary":"LENSAR Q2 revenue rises 18%, returns to profitOverviewUS robotic cataract laser maker's Q2 revenue grew 18% yr/yr, recurring revenue up 20%Net income turned positive, aided by improved revenue and low","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A0H0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","LNSR","BK4588","STAA","LENZ","BK4082","BK4139","BK4007","BK4539","BK4585","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659156276","title":"Global-E Online Ltd. : Bofa Global Research Raises Price Objective to $52 from $44","url":"https://stock-news.laohu8.com/highlight/detail?id=2659156276","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659156276?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:15","pubTimestamp":1786619750,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN44A19A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4220","BK4588","BK4122","GLBE","BK4585","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659015671","title":"Mobix Labs Signs Deal to Acquire Rare Earth Supply-Chain Platform Special Project Delivery in All-Stock Transaction","url":"https://stock-news.laohu8.com/highlight/detail?id=2659015671","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659015671?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:15","pubTimestamp":1786619716,"startTime":"0","endTime":"0","summary":"Mobix Labs signs deal to acquire rare earth supply-chain platform Special Project Delivery in all-stock transactionMobix Labs agreed to acquire Special Project Delivery in an all-stock deal capped at ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL2FyrPX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MOBX","BK4539","BK4141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659415620","title":"Mobix Labs, - Spd Acquisition Consideration not to Exceed 4.8 Mln Mobix Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2659415620","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659415620?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:15","pubTimestamp":1786619704,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN44A0NQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4141","BK4539","MOBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659274156","title":"Mobix Labs Signs Definitive Rare Earth Elements Deal, Expanding National Security Platform; Hosts Investor Call Today at 4:15Pm Et","url":"https://stock-news.laohu8.com/highlight/detail?id=2659274156","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659274156?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:15","pubTimestamp":1786619704,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN44A0NQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4141","MOBX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659715156","title":"Aveanna Healthcare Q2 Revenue Beats on Broad-Based Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2659715156","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659715156?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:15","pubTimestamp":1786619700,"startTime":"0","endTime":"0","summary":"Aveanna Healthcare Q2 revenue beats on broad-based growthOverviewUS home care provider's Q2 revenue rose 13.7%, beating analyst expectationsAdjusted EBITDA for Q2 increased 8.0% year-over-yearCompany ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A0GG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVAH","BK4539","BK4185","SGRY","PIII","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659562311","title":"Beyond Air Q1 Net Loss Slightly Widens, Reaffirms 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2659562311","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659562311?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:13","pubTimestamp":1786619594,"startTime":"0","endTime":"0","summary":"Beyond Air Q1 net loss slightly widens, reaffirms 2026 outlookOverviewUS medical device maker's Q1 revenue was flat yr/yr at $1.8 mlnCompany completed up to $30.1 mln financing to support commercial e","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A0GU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0251131958.USD","BK4139","LU0048573561.USD","BK4564","TDY","BK4157","EYES","LU0251142724.SGD","BZZ","BK4082","LU0742534661.SGD","BK4007","BK4585","XAIR","LQDA","VREX","BK4539","RNXT","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659315159","title":"Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE), Mineralys Therapeutics, Inc. (MLYS) and Adagene (ADAG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659315159","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659315159?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:10","pubTimestamp":1786619422,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Monte Rosa Therapeutics (GLUE), Mineralys Therapeuti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-monte-rosa-therapeutics-glue-mineralys-therapeutics-inc-mlys-and-adagene-adag-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-monte-rosa-therapeutics-glue-mineralys-therapeutics-inc-mlys-and-adagene-adag-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","LU0029874061.USD","HCSG","BK4539","GLUE","BK4139","LU0128526141.USD","BK4581","MLYS","BK4585","BK4137","XBI","ADAG","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659015615","title":"Lenz Therapeutics, Inc. : Bofa Global Research Cuts to Neutral from Buy; Cuts Price Objective to $7 from $31","url":"https://stock-news.laohu8.com/highlight/detail?id=2659015615","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659015615?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:08","pubTimestamp":1786619320,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN44A16B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LENZ","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659156955","title":"Aveanna Healthcare Shares up 7.3% Premarket After Q2 Revenue Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=2659156955","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659156955?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:05","pubTimestamp":1786619120,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL4N44A0VZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVAH","BK4196","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659156597","title":"Biomea Fusion Doses First Patient in OPAL Trial of Icovamenib Plus Semaglutide for Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2659156597","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659156597?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:03","pubTimestamp":1786619009,"startTime":"0","endTime":"0","summary":"Biomea Fusion doses first patient in OPAL trial of icovamenib plus semaglutide for obesityBiomea Fusion dosed the first participant in a new OPAL trial arm testing icovamenib with low-dose semaglutide","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDLVnzpX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","SG9999014039.USD","SG9999014021.USD","BCDF","BK4539","SG9999014005.SGD","BK4585","LU2095319765.USD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","BMEA","BK4139","SG9999014013.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU2210150020.SGD","LU0314104364.USD","NDAQ","IE00BKPKM429.USD","LU2210149790.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":54,"pageCount":37,"totalSize":1079,"code":"91000000","status":"200"}]}}